S.H. Laval

569 total citations
12 papers, 250 citations indexed

About

S.H. Laval is a scholar working on Molecular Biology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S.H. Laval has authored 12 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Rheumatology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S.H. Laval's work include Muscle Physiology and Disorders (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Myasthenia Gravis and Thymoma (2 papers). S.H. Laval is often cited by papers focused on Muscle Physiology and Disorders (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Myasthenia Gravis and Thymoma (2 papers). S.H. Laval collaborates with scholars based in United Kingdom, Germany and Belgium. S.H. Laval's co-authors include Trivadi S. Ganesan, Andrew N. Shelling, Robin Butler, Hanns Lochmüller, A M Hanby, Richard Poulsom, Volker Straub, M. Roberts, E. Martoni and Donald P. Doolittle and has published in prestigious journals such as Human Molecular Genetics, Journal of the Neurological Sciences and Genomics.

In The Last Decade

S.H. Laval

12 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.H. Laval United Kingdom 7 136 82 64 54 39 12 250
R Kramer United States 4 226 1.7× 104 1.3× 42 0.7× 73 1.4× 46 1.2× 6 376
Sylvie Pellerin France 9 265 1.9× 44 0.5× 46 0.7× 48 0.9× 18 0.5× 12 346
M Takeichi Japan 7 239 1.8× 51 0.6× 26 0.4× 69 1.3× 10 0.3× 9 331
Kandice L. Tessneer United States 9 179 1.3× 36 0.4× 34 0.5× 51 0.9× 15 0.4× 16 292
Miesje M. van der Stoel Netherlands 10 170 1.3× 30 0.4× 43 0.7× 123 2.3× 11 0.3× 17 314
Jeongsuk Choi South Korea 7 155 1.1× 257 3.1× 35 0.5× 96 1.8× 27 0.7× 8 388
Sarah Etheridge United Kingdom 7 173 1.3× 19 0.2× 26 0.4× 82 1.5× 14 0.4× 10 297
Akira Nagabukuro Japan 8 267 2.0× 61 0.7× 22 0.3× 33 0.6× 31 0.8× 12 458
Brian W. Rigatti United States 10 290 2.1× 67 0.8× 82 1.3× 173 3.2× 26 0.7× 13 401
Deborah Bielser United States 7 387 2.8× 99 1.2× 73 1.1× 89 1.6× 13 0.3× 7 536

Countries citing papers authored by S.H. Laval

Since Specialization
Citations

This map shows the geographic impact of S.H. Laval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.H. Laval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.H. Laval more than expected).

Fields of papers citing papers by S.H. Laval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.H. Laval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.H. Laval. The network helps show where S.H. Laval may publish in the future.

Co-authorship network of co-authors of S.H. Laval

This figure shows the co-authorship network connecting the top 25 collaborators of S.H. Laval. A scholar is included among the top collaborators of S.H. Laval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.H. Laval. S.H. Laval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Reza, Mojgan, et al.. (2016). Optimization of Internally Deleted Dystrophin Constructs. Human Gene Therapy Methods. 27(5). 174–186. 2 indexed citations
2.
3.
Salih, Mustafa A., Mohammed Zain Seidahmed, Heba Y. El Khashab, et al.. (2015). Salbutamol benefits children with congenital myasthenic syndrome due to ALG2 mutation. Journal of the Neurological Sciences. 357. e72–e72. 2 indexed citations
4.
Dick, Emily, Spandan Kalra, D. N. Anderson, et al.. (2013). Exon skipping and gene transfer restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutations. Stem Cells and Development. 777275616–777275616. 7 indexed citations
5.
Hicks, Debbie, S.H. Laval, James J. Collins, et al.. (2013). Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy. Human Molecular Genetics. 23(9). 2353–2363. 81 indexed citations
6.
Harris, Elizabeth, S.H. Laval, Judith A. Hudson, et al.. (2013). Undiagnosed Genetic Muscle Disease in the North of England: an in Depth Phenotype Analysis. PLoS Currents. 5. 5 indexed citations
7.
Wood, Alasdair J., Juliane Müller, Catherine D. Jepson, et al.. (2011). Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency. Human Molecular Genetics. 20(24). 4879–4890. 20 indexed citations
8.
Brown, Matthew A., S.H. Laval, Andrew E. Timms, et al.. (2000). Confirmation of non-MHC genetic loci by whole genome linkage studies in ankylosing spondylitis.. Queensland's institutional digital repository (The University of Queensland). 43(9). 1 indexed citations
9.
Eyre, Stephen, Jeff Barrett, S.H. Laval, et al.. (2000). Linkage analysis of potential rheumatoid arthritis non-HLA susceptibility loci.. Oxford University Research Archive (ORA) (University of Oxford). 43. 1 indexed citations
10.
Shelling, Andrew N., et al.. (1995). Localization of an epithelial-specific receptor kinase (EDDR1) to chromosome 6q16. Genomics. 25(2). 584–587. 17 indexed citations
11.
Laval, S.H., Robin Butler, Andrew N. Shelling, et al.. (1994). Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line.. PubMed. 5(11). 1173–83. 62 indexed citations
12.
Lalley, P.A., J. Peters, Donald P. Doolittle, et al.. (1990). Report of the comparative subcommittee for human and mouse homologies. Cytogenetic and Genome Research. 55(1-4). 434–456. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026